| NCT Number | NCT07307833 |
| Lead Sponsor | Mayo Clinic |
| Conditions | Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm |
| Enrollment | 50 participants |
| Start Date | 2025-10-31 |
| Primary Completion | 2027-10-31 (estimated) |
| Study Completion | 2029-10-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-16 |